European Medical Market Aurora Europe GmbH is a leading medical cannabis importer and distributor in Europe, with a Berlin base and a robust EU GMP facility network. This suggests sales opportunities in European healthcare providers, pharmacies, and clinics seeking compliant supply of medical cannabis products.

Strategic Acquisition The 2017 Pedanios acquisition signals a proven integration track record and expanded EU distribution reach. Target opportunities may include partners seeking to leverage an established European cannabis supply chain and regulatory know-how.

Public Relations & Events Participation in industry events such as CB Expo indicates active engagement with stakeholders and policymakers. Leverage this visibility to open conversations with hospital networks, patient advocacy groups, and regulators about standardized cannabis programs.

Global Cannabis Link As a subsidiary of Aurora Cannabis Inc., Aurora Europe benefits from global branding and product pipelines. Explore cross-border sales of branded medical cannabis products, accessory offerings, or value-added services to European healthcare customers aware of the parent company.

Growth Constraints & Focus Revenue is currently in a low range, suggesting a market with room for expansion through new partnerships, channel diversification, and digital engagement. Sales conversations can target EU distributors, hospital networks, and private clinics looking for scalable, compliant supply.